Insider Transactions last 24 months for Kyverna Therapeutics, Inc.  -  NSDQ: KYTX

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Cohen Fred EDirector05/29/2025AADirectCOM16,634$0.00$0.0016,634
Clark Ian TDirector05/29/2025AADirectCOM16,634$0.00$0.0016,634
Aktar MertDirector05/29/2025AADirectCOM16,634$0.00$0.0016,634
Spiegelman Daniel KDirector05/29/2025AADirectCOM16,634$0.00$0.0016,634
Seidenberg Beth CDirector05/29/2025AADirectCOM16,634$0.00$0.0016,634
Shaw ChristiDirector05/29/2025AADirectCOM16,634$0.00$0.0016,634
Walker Karen MarieChief Technology Officer04/11/2025AADirectCOM13,000$0.00$0.0022,636
Jones Ryan AlexanderChief Financial Officer04/11/2025AADirectCOM12,000$0.00$0.0055,950
Walker Karen MarieChief Technology Officer06/06/2024AMDirectCOM9,636$4.42$42,591.129,636
Jones Ryan AlexanderChief Financial Officer05/28/2024AMDirectCOM7,146$0.73$5,216.5843,950
Jones Ryan AlexanderChief Financial Officer05/28/2024AMDirectCOM10,870$0.73$7,935.1036,804
Northpond Ventures Iii Gp, LlcOther02/12/2024APIndirectCOM450,000$22.00$9,900,000.00450,000
Northpond Ventures Iii Gp, LlcOther02/12/2024ACIndirectCOM2,805,426$0.00$0.002,805,426
Bain Capital Life Sciences Investors, LlcOther02/12/2024APIndirectCOM450,000$22.00$9,900,000.003,163,868
Bain Capital Life Sciences Investors, LlcOther02/12/2024ACIndirectCOM2,713,868$0.00$0.002,713,868
Seidenberg Beth CDirector02/12/2024ACIndirectCOM735,984$0.00$0.00735,984
Seidenberg Beth CDirector02/12/2024ACIndirectCOM3,787,940$0.00$0.003,787,940
Cohen Fred EDirector02/12/2024ACIndirectCOM4,523,924$0.00$0.004,523,924
Vida Ventures, LlcOther02/12/2024APIndirectCOM583$22.00$12,826.00583
Vida Ventures, LlcOther02/12/2024APIndirectCOM252,553$22.00$5,556,166.00252,553
Vida Ventures, LlcOther02/12/2024ACIndirectCOM4,523,924$0.00$0.004,523,924
Gilead Sciences, Inc.Other02/12/2024APDirectCOM910,000$22.00$20,020,000.004,126,119
Gilead Sciences, Inc.Other02/12/2024ACDirectCOM3,216,119$0.00$0.003,216,119
Westlake Biopartners Fund I, L.P.Other02/12/2024ACIndirectCOM735,984$0.00$0.00735,984
Westlake Biopartners Fund I, L.P.Other02/12/2024ACIndirectCOM3,787,940$0.00$0.003,787,940
1   You are at page 1 of 1 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel